BMC Medicine (Oct 2024)

Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

  • Yanhua Song,
  • Wei Shu,
  • Yi Pei,
  • Juan Du,
  • Guihui Wu,
  • Hua Wang,
  • Fengling Mi,
  • Fangchao Liu,
  • Liping Ma,
  • Li Xie,
  • Zhongshun Kong,
  • Xiaoguang Wu,
  • Rongmei Liu,
  • Hongmei Chen,
  • Hua Li,
  • Qiping Ge,
  • Lihui Nie,
  • Zizheng Lv,
  • Xuerui Huang,
  • Mingwu Li,
  • Mingying Jiang,
  • Xiaohong Chen,
  • Qingshan Cai,
  • Wei Chen,
  • Yanmei Liu,
  • Yanfang Miao,
  • Yan Tang,
  • Yu Chen,
  • Shujun Geng,
  • Quanying Zhou,
  • Yuhong Liu,
  • Yu Pang,
  • Mengqiu Gao

DOI
https://doi.org/10.1186/s12916-024-03694-4
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 2

Abstract

Read online

No abstracts available.